The new AHA/ACC recommendations on peripheral artery disease (PAD) extend more broadly across the spectrum of PAD care. The guidelines’ vice chair explains why they’re more of a reboot than an update.
TMAO Implicated in PAD Mortality Risk
A cohort study has tied the gut microbial metabolite TMAO to elevated five-year mortality in patients with peripheral artery disease (PAD). Here’s how treatment targeting in PAD may be shaped in response.